Headache, fever, MSID Flashcards

1
Q

Tension type headache

A
Location: bilateral 
Nature: diffuse ache to tight pressing, constricting pain
Onset: gradual
Duration: minutes to days
Non-headache symptoms: scalp tenderness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Migraine headache

A
Usually unilateral 
Throbbing; may preceded by an aura
Onset suddenly 
Hours to 2 days
Nausea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Sinus headache

A

Face, forehead or preorbital area
Pressure behind eyes or face; dull; bilateral pain, worse in the AM
Onset simultaneous with sinus symptoms, including nasal discharge
Duration Days Resolves with sinus symptoms
Nasal congestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Secondary headaches (medications that cause headaches)

A
Blood-pressure lowering 
medication
Antibiotics
Oral contraceptives 
Vasodilators
Over of medications: ergot derivatives, opioids, nonopiod agents, triptans
Caffeine withdrawal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Secondary headache ( medication overuse symptoms and treatment)

A

Frequent use >3 month and from stopping medication
Continuous HA: waking, increase with frequency
TX: need to taper the medication to eliminate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Exclusions for self treatment HA

A

Severe head pain
Headache that persists for 10 days with or without treatment
Last trimester of pregnancy
<8 years of age
High fever or signs of serious infection
History of liver disease disease or consumption of 3or more alcoholic drinks per day
Secondary headache ( except minor sinus headache)
Symptoms consistent with migraine without formal diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

General treatment for episodic tension type headaches

A

Apap
NSAID
Salicylate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

General treatment for chronic tension type headaches

A

Candidates for prescription medications
If using OTC, limit to 3 days per week
Benefit from non pharmacologic treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

General treatment for migraine headaches

A

Medical diagnosis is required before self treatment

Treat with NDAID or salicylate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

General treatment for sinus headache

A

Decongestant and/or OTC analgesic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nonpharmacologic therapy of chronic tension headaches

A

Relaxation exercise

Physical therapy focused on stretching and strengthening of head and neck muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Nonpharmacological treatment for migraines

A

Regular sleeping and eating schedule
Methods for coping with stress
Ice+pressure to forehead or temple are
Dietary: Avoid Food that triggers; avoid hunger or low blood glucose; magnesium supplements; avoid food with nitrates, tyramine, phenylalanine, monosodium glutamate ( msg), caffeine and theobromine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MOA of APAP

A

Inhibitors of prostaglandins synthesis centraly
Not an anti inflammatory
Not considered NSAID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Indications for APAP

A

Analgesic ( mild to moderate pain of non visceral origin)

Antipyretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Onset of APAP

A

30 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Duration of APAP

A

Four hours, 6-8 hours with ER formulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

DI with APAP

A

Alcohol

Warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

APAP Dosing

A

Adult dosing:
325 mg - 1000 mg 4-6 hours ( MDD 4000mg)

New dosing: extra strength tablets (500mg): 2tab every 6 hours ( MDD 3000 mg)
Regular strength tablets (325mg): MDD 3250 mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

APAP pediatrics dosing

A

10-15 mg/kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Acute overdose of APAP

A

One time dose 10g or more leading acute liver failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Chronic overdose of APAP

A

Daily dose more than 4 g for several weeks leading acute liver failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Prevention of overdose of APAP

A

Follow dosing instructions and max daily dose exactly as on package labeling
Read labels of all medications to avoid excess APAP
Conservative dosing (2g/day or less) in patients at risk for hepatotoxicity:
-Concurrent use of other potential hepatotoxic drugs
-Poor nutrition intake
-Ingestion of 3 or more alcoholic drinks per day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Symptoms of overdose of APAP

A

Early symptoms: nausea, vomiting, drowsiness, confusion, abnormal pain. Or no symptoms
Serious clinical manifestation: begin 2-4 days after acute ingestion; increased liver enzymes ( alt/ast); increased plasma bilirubin w/jaundice; prolonged prothrombin time; obtuntation
Majority of cases, hepatic damage is reversible over week-months but fatal hepatic necrosis can occur
Refer to poison control center/ER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

NSAID salicylate

A

ASA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

NSAID non acetylated salicylate

A

Magnesium salicylate

Choline salicylate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Non salicylate nsaid

A

Ibuprofen
Ketoprofen
Naproxen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

NSAID MOA

A

Anti inflammatory: nsaid decreases prostaglandins synthesis via inhibitions of cox1 and cox2 ( non selective)

  • ASA irreversibly binds to receptors
  • Ibuprofen, ketoprofen, naproxen reversible binds to receptors

Analgesic and antipyretic Activity: inhibit the production of prostaglandin synthesis resulting in reduced nonciceptor sensitization and increase pain threshold.

  • temperature-inhibition of PGE2
  • Analgesic-inhibition of PGE and PGF

Platelet Effect: the inhibition of platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Indications for no salicylate nsaid

A

Fever
Minor pain from headaches, common cold, toothache, muscle aches, backache, arthritis, menstrual cramps
Mild-moderate pain of non visceral origin
Inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Non salicylate nsaid ADR:

A

GI: dispepsia, heartburn, nausea, anorexia, epigastric pain, peptic ulcer, bleeding
Dizziness, rash, fluid retention, renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Non salicylate nsaid CI

A

-increased risk for MI,heart failure, hypertension, stroke
-patients at risk for CV should avoid: hyperlipidemia, HTM, DM
All patients, use lowest dose for shortest duration:
-history of GI bleeds
-asthma
-impaired renal/hepatic function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Non salicylate nsaid DDI

A

NSAID and ASA ( cardio protection): take ASA 30 min before or 8 hr after: allowing ASA time to bind irreversible
PHenytoin:displacement from protein binding sites
Bisphosphonates: increased risk of GI irritation
Digoxin: inhibition of digoxin renal clearance
Anti hypertensive effects inhibited ( BB, ACE-I, Vadodilators, diuretics)
Anticoagulant: increased risk of bleeding
Alcohol:increased risk of bleeding
Methotrexate: decreased clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Ibuprofen dosing

A

> 12 yo 200-400 mg Q 4-6 hr 1200mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Naproxen dosing

A

12-65 220 mg Q 8-12 hr max 660mg/day
>65 yo 220mg Q 12 hr max 440 mg/day
Aspirin 650-1000mg Q 4-6 hr 4000 mg/ day
Not recommended younger than 12 years old

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

ASA dosing

A

650-1000 mg Q 4-6 hr max 4000mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Ibuprofen pediatric dosing

A

5-10 mg/kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Salicylate indications

A

Treatment of symptoms Of osteoarthritis, rheumatoid arthritis
Temporary relief of minor aches And pains from backache and muscle aches
Mild-moderate pain from musculoskeletal conditions/fever
ASA: prevention of thromboembolic events ( MI and Stroke)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Salicylate drugs interactions

A

Nsaid and ASA
Valporic acid: Displacement from protein binding site And incubation of metabolism
Nsaid and anticoagulants, alcohol: increased GI bleeding
Antihypertensive effect inhibited ( BB, ACE I, vasodilator, diuretic)
Methotrexate: decreased clearance
Sulfonylureas: increased risk of hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Salicylate ADR

A

GI : dyspepsia, epigastric discomfort
Gastritis ulceration of upper GI tract
- penetrates protective mucous and bicarbonate layers of gastric mucosa, allowing back diffusionof acid leading to cellular and vascular erosion: local irritant effect from medication contacting gastric mucosa and systemic effect from prostaglandins inhibition
GI blood loss is dose dependent
Aspirin intolerance:
-urticaria-angioedema and bronchi spastic ( risk factor: asthma with nasal polyps )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

ASA CI

A

Discontinue 3 days before fecal occult blood testing
Discontinue 2-7 days Before surgery
Do not use to relive pain after any surgery
In patients with hypothrombinemia, vitamin K deficiency, hemophilia, history of bleeding disorder, history of peptic ulcer disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Sodium salicylate CI

A

Does not affect platelets but can increase prothrombin time

Avoid in patients who are sodium restricted ( heart failure, HTN, renal failure)

41
Q

Magnesium salicylate CI

A

Caution in patients with renal impairment ( accumulation of magnesium)

42
Q

All Salicylates CI

A

Avoid in history of gout or hyperuricemia ( does of 1-2 g inhibit Uric acid secretion)

43
Q

Salicylates : Reye’s syndrome

A

Acute illness occurring exclusively in children <15 yo
Progressive neurologic they damage, fatty liver with encephalopathy, hypoglycemia
Mortality as high as 50%
Cause unknown onset follows viral infection with influenza or varicella zoster
Warning:aspirin and other salicylate Should be avoided in children and young adults who have influenza and chickenpox

44
Q

Regular aspirin

A

Non ionized drug absorbed in the stomach and small intestine

45
Q

Enteric coated aspirin

A

Absorbed only in small intestine
Absorption slowed by food
Hypochlorhydria may cause dissolution in the stomach
Not for patients who need rapid pain relief

46
Q

Salicylate suppository

A

Absorption slow and unreliable

47
Q

Buffered aspirin

A
Buffers to decrease GI irritation:
Aluminum hydroxide
Magnesium carbonate
Calcium Carbonite
Sodium bicarbonate 
Absorbed more rapidly than non buffered, but time to onset is not improved much
More expensive
48
Q

Sustained-release aspirin

A

ProlongsDuration of action by slowing dissolution and absorption

49
Q

Salicylates Toxicity

A

Salicylism: mild salicylate intoxication

  • 90-100mg/kg for at least 2 days
  • HA, confusion, dizziness, difficulties hearing, vision changes, n/v, sweating

Acute intoxication:

  • Mild (<150mg/kg) to severe( >300mg/kg)
  • lethargy, tinnitus, tachypnea, pulmonary edema, convulsions, coma, n/v, acid-base disturbance, dehydration, hemorrhage, hypoglycemia
50
Q

Choline salicylate dosing

A

870 mg q3-4h ( 5220mg/d)

Do not give for patients younger than 15 years old

51
Q

Ketoprofen dosing

A

12.5-25 mg q4-6 hr( 75mg/d)

Not recommended for patients younger than 16 years old

52
Q

Normal body temperature

A

Between 97.5-98.9

53
Q

Fever

A

Regulated rise in the body temperature maintained by the hypothalamus in response to a pyrogen
Increase in the body thermoregulatory set point

54
Q

Hyperthermia

A

Uncontrolled elevation invited temperature without elevation of hypothalamic set point

55
Q

Hyperpyrexia

A

Body temperature >106f resulting in mental and physical consequences
Caused by pyrogen or hyperthermia

56
Q

Causes of fever

A
Idiopathic 
Microbial infections
Tissue damage
Malignancies 
Antigen antibody rnx 
Dehydration
Heatstroke
CNS inflammation
Metabolic disorders
Drug fever from 98.9 to 109f
Pyrogens: 
-exogenous (microbes toxins): did not independently increase hypothalamic set point; stimulate release of endogenous pyrogens
-exogenous ( immune cytokines): causes production of PGE2; PGE2 elevates thermoregulatory st point
57
Q

Complications of fever

A

Most fevers are self-limiting and nonthteatening:
-headache, diaphoresis, generalized malaise, chills, tachycardia, arthralgia, myalgia, irritability, anorexia
-disorientation and delirium
Major risk: seizures, dehydration, change in mental status

58
Q

Rectal thermometer

A

Normal range: 97.9-100.4
Fever: > 100.4
Gold standard, most accurate

59
Q

Oral thermometer

A

Normal range: 95.9-99.5

Fever: >99.5

60
Q

Axillary thermometer

A

Normal range 94.5-99.3

Fever >99.3

61
Q

Temporal thermometer

A

Normal range97.9 -100.1
Fever: > 100.7for two months old
>100.3 for 3-4 months old
> 100.1 for >4 months old

62
Q

Tympanic thermometer

A

Normal range 96.3 - 100

Fever more than 100

63
Q

Exclusions to self care of fever

A

Children older than six months with rectal temperature more than 104 or equivalent
Infants younger than six months with rectal temperature more than 101
Severe symptoms of infection that are not self-limiting
Risk of hyperthermia
Impaired oxygen utilization( sever Copd, respiratory distress, heart failure)
Impaired immune function HIV cancer
CNS They Mitch head trauma Stroke
Children with history of febrile seizures
Fever persists more than three days three days with or without treatment
Child who: develops spot or rash; refuses to drink fluids , is sleepy , irritable or hard to wake up; Is vomiting and cannot keep fluids down

64
Q

Recommended nonpharmacologic treatment for fever

A

Adequate fluid intake:
-children: increased by 30-60 ml of fluid per hour
-adults: Increased by 60-120 ml Of fluids per hour
-Caution recommending fruit juice in patients with diarrhea
Wear lightweight closing
Remove blankets
Maintain comfortable room temperature of about 68f

65
Q

Did not recommend nonpharmacological treatment

A

Sponging or baths= Limited utility
Icewater bath
Sponging with hydroalcoholic solutions

66
Q

Pharmacologic therapy

A

Antipyretic: inhibit pge2 synthesis => Decreasing hypothalamic set point
APAP: Takes 30 min to 1 hour to begin did you please temperature or discomfort; Reaches maximum temperature reduction at two hours
Ibuprofen: Text half an hour to an hour to degrees temperature or discomfort ; reaches maximum temperature reduction two hours

67
Q

Monitoring fever

A

In Most patients reduction in temperature seen after each individual dose
In some patients Pharmacologic therapy may take up to one day to result in decrease in temperature
Monitor temperature 2-3 times a day

68
Q

Referral to medical provider ( fever)

A

If fever or discomfort persists or worsens after three days of Drug treatment

69
Q

MSID

A

Musculoskeletal injuries and desorders

70
Q

Somatic pain( MSID)

A

Arise from: Bone, Joint, muscle,connective tissue

Symptoms: Aching , squeezing stabbing, throbbing ; well localize patient then identify the source

71
Q

Visceral pain( MSID)

A

Arise from internal organs
Symptoms dull and crumpy
Injury it to organ capsule or other structure pain more localized and sharp

72
Q

Neuropathic pain ( MSID)

A

Abnormal processing of sensory input by peripheral or CNS: Spontaneous pain transmission
Symptoms Burning, tingling shock like shooting

73
Q

Acute pain( MSID)

A

10 days or less
Triggered by tissue damage
Ex. Tendinitis ,sprain, strain

74
Q

Chronic pain(MSID)

A

Six months or longer
More than 14 days if you have been trying to Treat
Continued pain after the injury is healed
Associated with ongoing or progressive disease
Ex: degenerative joint disease ( DJD) or osteoarthritis

75
Q

Common musculoskeletal disorders

A
Myalgia 
Tendinitis 
Bursitis 
sprain
Strain 
Osteoarthritis ( APAP is first line
Low back pain: acute: candidates for self care 
Chronic: Medical Evolation first
Overexertion
76
Q

Exclusions for self-care ( MSID)

A

Moderate to severe pain score more than six
Pain that lasts more than 10 days
Pain that continues more than seven days after treatment with topical analgesics
Increased intensity or change in character of pain
Pelvic or abdominal pain other than dysmenorrhea
N/V or fever or other signs of infection
Visually deformed Joint, Abnormal movement weakness in any Limb or suspected fracture
Third trimester of pregnancy
Less than two years of age

77
Q

General treatment considerations ( MSID)

A

Use scheduled doses of non-prescription strength analgesics early in course of injury
Quickly taper dose and dosing interval as the injury improves ( 1-3 days)
Follow up: If plane has not improved in 10 days seek medical attention

78
Q

Nonpharmacologic therapy MSID

A

RICE: rest ice compression elevation
Preventing sports exercise injuries: warming up or stretching; proper hydration
Muscle cramps: Stretching and message and the affected area immediately then the rest or reduced activity
Chairs with back support and Ergonomic keyboards
Heat therapy

79
Q

Heat therapy MSID

A

For noninflammatory pain (acute low back pain ) and Osteoarthritis:
-Did not apply to recent injuries less than 48 hours or inflamed area( will intensify vasodilation and exacerbate vascular leakage and tissue damage)
Did not use Waze other topical agents or over broken skin
Did not to use heating devices on area of skin with decreased sensation

Warm wet compresses heating pads or hot the water bottles:
-apply heat for 15 or 20 minutes 3 to 4 times a day

Heat-generating adhesive and wrap products:

  • Warn for up to eight hr to 12 hours for arthritis products
  • thermacare products should not be used on the palm of the hand, back of the knee or bend of the arm
  • remove patch immediately if pain , discomfort, itching, or burning

Heat wraps:

  • should be warn over clothing in patients over 55 yo
  • should not be used while sleeping
80
Q

Counterirritants

A

Paradoxical pain-relieving effect achieved by producing a less severe pain to counter a more intense one
Psychological component:
- met exert placebo effect through pleasant odors or sensations of warmth/coolness

Indications:

  • temporary relief of minor aches and sprains of muscles and joints
  • simple backache, arthritis pain, strains, bruises and sprain
81
Q

Rubefacients ( increase blood flow)

A

Methyl salicylate 10-60%
Turpentine 6-50%
Allyl isothiocynate 0.5-50%
Ammonia water 1-2.5%

Applying no more often then 3 to 4 times a day for up to seven days

82
Q

Counterirritants produced cooling sensation

A

Camphor 3-11%
Menthol 1.25 -16.0 %
Apply no more often than 3 to 4 times a day for up to seven days

83
Q

Counterirritants caused vasodilation

A

Menthyl nicotinate 0.25-1
Histamine dihydrochloride 0.025-0.1

Apply no more often than 3 to 4 times a day for up to seven days

84
Q

Counterirritants: irritation without rubefaction

A

Capsicum, capsaicin 0.025-0.25%

Acute pain: apply no more often then 3 to 4 times a day for up to seven days

Chronic pain: Apply 3 to 4 times a day for duration of pain

85
Q

Methyl Salicylate

A

Occurs naturally as wintergreen oil or sweet birch oil: also known as gaultheria oil, teaberry oil, or mountain tea

MOA: rubefacient: Causes vasodilation of cutaneous vasculature producing hyperemia
Also inhibits prostaglandins synthesis peripherally and centrally, acting as anti-inflammatory agent
Direct tissue penetration suggests local effect

86
Q

Methyl Salicylate ADR

A

Skin irritation or rush
Erythema, blistering, neurotoxicity , thermal hyperalgesia
Salicylate Toxicity

87
Q

Methyl Salicylate Precautions

A

Absorption increases with: Heat pads or heat exposure, exercise
Avoid in children
Avoid in patients with severe asthma or nasal polyps
Avoid in patients with sensitivity to aspirin

88
Q

Camphor MOA

A

Concentrations 0.1-3% depress cutaneous receptors( Used as analgesic,antipyretic, anesthetic)
Concentrations more than 3% stimulates nerve endings in the skin and induce pain relieve and discomfort by Making Moderate-severe deeper visceral pain with a milder pain arising From the skin at the level of innervation
When applied vigorously, it produces a rubefacient rxn

89
Q

Camphor precautious

A

CNS Toxicity ( tonic-clonic seizures) Following ingestion
Placing in Nostrils of infants can cause respiratory collapse
Caution with vapo-rub products

90
Q

Menthol MOA

A

Extracted from peppermint oil or prepared synthetically
Concentrations less than 1% acts as anesthetic and depresses cutaneous response
Concentrations more than 1.25% stimulates cutaneous receptor response ( counterirritants)
Triggers cold sensation that travels along pathways similar to somatic pain sensations from that affected muscle or joint, which distracts from the pain sensation
Initial feelings of coolness followed by sensation of warmth

91
Q

Menthol CI

A

Hypersensitivity or Sensitization

92
Q

Methyl nicotinate MOA

A

Causes vasodilation and elevation of skin temperature

Partially mediated by prostaglandins Biosynthesis

93
Q

Methyl nicotinate ADR

A

Blood pressure decrease decrease in Pulse rate

Syncope From generalized vascular dilation

94
Q

Capsicum MOA

A

Naturally occurring
Depletes substance P from sensory neurons implicated in mediating cutaneous Pain
Causes burning pain or sensation

95
Q

Capsicum Indication

A

Reduces pain Butts not inflammation of rheumatoid arthritis, osteoarthritis
Also used in postherpetic neuralgia, psoriasis, diabetic neuropathy

96
Q

Capsicum dosing

A

Need to use every day 3 to 4 times a day for efficacy
Duration of action 4 to 6 hours
Pain relief takes 14 days up to 4 to 6 weeks

Apply With gloves or applicator and wash hands following use
Do not touch sensitive areas (eyes) or apply to Wounds for damage skin
Discontinue temporarily of skin breakdown occurs (Read, weeping, small ulcers).

97
Q

Trolamine Salicylate MOA

A

Category three: Insufficient data are available to establish safety and efficacy during pregnancy

Salicylate salt
Absorbed through the skin lead-in to salicylate concentrations in synovial fluid slightly below those of oral aspirin

98
Q

Trolamine Salicylate dosing

A

10-15% concentration applied to affected area not more Than 3 to 4 times a day
For adults and children more than two years old

Same drug interactions and CI As other salicylates
Avoid Contact with eyes and mucous membranes